News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Dolutegravir knocks down HIV faster than bictegravir in French study
06 Oct 2026
byElvira Manzano
Final analysis of the BicDol study, presented at AIDS 2026, suggests that a first-line triple antiretroviral regimen containing dolutegravir suppresses HIV more rapidly than one containing bictegravir, particularly among patients with the highest viral loads.
06 Oct 2026







